HyperTETS/D (GRIFOLS USA, LLC)
Welcome to the PulseAid listing for the HyperTET drug offered from GRIFOLS USA, LLC. This pharmaceutical is classified as a PLASMA DERIVATIVE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same PLASMA DERIVATIVE drug type category.
LABELER NAME / MANUFACTURER: | GRIFOLS USA, LLC |
NON-PROPRIETARY NAME: | Tetanus Immune Globulin (Human) |
SUBSTANCE NAME: | HUMAN CLOSTRIDIUM TETANI TOXOID IMMUNE GLOBULIN |
TYPE: | PLASMA DERIVATIVE |
PHARMA CLASS: | |
ROUTE: | INTRAMUSCULAR |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | BLA |
START MARKETING DATE: | 1996-08-14 |
END MARKETING DATE: | 0000-00-00 |
HyperTET S/D PLASMA DERIVATIVE Details:
Item Description | HyperTET S/D from GRIFOLS USA, LLC |
LABELER NAME: | GRIFOLS USA, LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 250([iU]/mL) |
START MARKETING DATE: | 1996-08-14 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 13533-634_837a9dc8-28c8-48af-b18b-1620f67c7527 |
PRODUCT NDC: | 13533-634 |
APPLICATION NUMBER: | BLA101142 |
Other HUMAN CLOSTRIDIUM TETANI TOXOID IMMUNE GLOBULIN Pharmaceutical Manufacturers / Labelers: